The Cardiovascular Prevention Program
- Conditions
- Cardiovascular Prevention
- Interventions
- Other: International Physical Activity QuestionnaireOther: Six minute walking testOther: SF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21.Other: MEDASOther: Intima-media thickness (IMT)Biological: Blood samplingBiological: Stool Sample Culture Test
- Registration Number
- NCT06362538
- Lead Sponsor
- Maria Cecilia Hospital
- Brief Summary
Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths respectively. In Italy, the situation in terms of deaths due to cardiovascular diseases it is in line with the world ranking and European, being responsible for 44% of all deaths. The only interventional or pharmacological approach is neither effective nor sustainable. The most deaths from cardiovascular diseases are due to atherothrombotic events, which are attributable to a series of risk factors, most of which are modifiable. Turns out itself as a targeted action on these factors with the aim of safeguarding the state of health cardiovascular, may represent the best applicable strategy. It is therefore necessary structure and activate prevention programs aimed at the general population and groups of subjects at higher risk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- primary prevention: age ≥ 30 years with a negative history of cardiovascular events
- secondary prevention: age ≥ 30 years with a negative history of cardiovascular events
- severe obesity
- high-grade renal failure
- severe and/or dialysis
- oncological disease in active phase
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description subject with a negative or positive history of cardiovascular disease Stool Sample Culture Test no drugs or devices are included. subject with a negative or positive history of cardiovascular disease SF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21. no drugs or devices are included. subject with a negative or positive history of cardiovascular disease Intima-media thickness (IMT) no drugs or devices are included. subject with a negative or positive history of cardiovascular disease Blood sampling no drugs or devices are included. subject with a negative or positive history of cardiovascular disease International Physical Activity Questionnaire no drugs or devices are included. subject with a negative or positive history of cardiovascular disease Six minute walking test no drugs or devices are included. subject with a negative or positive history of cardiovascular disease MEDAS no drugs or devices are included.
- Primary Outcome Measures
Name Time Method Adherence to the Mediterranean diet 12 months Mediterranean Diet Adherence
blood glucose test 12 months evaluation of blood glucose
blood pressure measurement 12 months Evaluation of Diastolic Blood Pressure
measure of body mass index 12 months BMI Assessment
blood test to check cholesterol levels 12 months Assessment of hypercholesterolemia
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
MCH
🇮🇹Cotignola, Ravenna, Italy